搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
2 天
on MSN
How Alcohol Affects Your Digestive System: Here's How Drinking Raises Risk Of Liver Disease
While the debate on alcohol consumption may continue, the evidence of its harmful effects is clear. From gastrointestinal ...
2 天
Triveni Bio Raises $115 Million Series B Financing to Expand Pipeline of Therapeutics ...
Triveni Bio Inc., a biotech company advancing novel antibody treatments for I&I disorders, today announced a $115 million ...
来自MSN
2 天
Pancreatitis: What It Is, Causes, Symptoms, Diet & Treatment
This article will explore what pancreatitis is, both acute and chronic. Discover what sets off this condition, it telltale signs and the diverse approaches to treatment, including medical procedures, ...
Psychology Today
2 天
GLP-1 Agonists May Help Treatment of Mental Illness and Substance Use
Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...
4 天
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of ...
Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative ...
Business Wire
6 天
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈